Find Roflumilast manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 162401-32-3, Daxas, 3-(cyclopropylmethoxy)-n-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide, Daliresp, By217, Byk20869
Molecular Formula
C17H14Cl2F2N2O3
Molecular Weight
403.2  g/mol
InChI Key
MNDBXUUTURYVHR-UHFFFAOYSA-N
FDA UNII
0P6C6ZOP5U

Roflumilast
Roflumilast is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3',5'-adenosine monophosphate (cAMP) and cAMP-mediated signaling. cAMP prevents phosphorylation of spleen tyrosine kinase (SYK) and abrogates activation of the PI3K/AKT/mTOR signaling pathway, which may result in the induction of apoptosis. PDE4, a member of the PDE superfamily that hydrolyses cAMP and 3',5'-cyclic guanosine monophosphate (cGMP) to their inactive 5' monophosphates, is upregulated in a variety of cancers and may contribute to chemoresistance; it also plays a key role in inflammation, especially in inflammatory airway diseases.
Roflumilast is a Phosphodiesterase 4 Inhibitor. The mechanism of action of roflumilast is as a Phosphodiesterase 4 Inhibitor.
1 2D Structure

Roflumilast

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide
2.1.2 InChI
InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)
2.1.3 InChI Key
MNDBXUUTURYVHR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F
2.2 Other Identifiers
2.2.1 UNII
0P6C6ZOP5U
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-di-chloropyrid-4-yl)benzamide

2. Daliresp

2.3.2 Depositor-Supplied Synonyms

1. 162401-32-3

2. Daxas

3. 3-(cyclopropylmethoxy)-n-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide

4. Daliresp

5. By217

6. Byk20869

7. By-217

8. B9302-107

9. By 217

10. 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide

11. Roflumilast (daxas)

12. Benzamide, 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)-

13. Byk-20869

14. 0p6c6zop5u

15. Chembl193240

16. Chebi:47657

17. 3-cyclopropylmethoxy-n-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide

18. Byk 20869

19. Mfcd00938270

20. B 9302-107

21. Rof

22. Libertek

23. Roflumilast [usan]

24. B-9302-107

25. Roflumilast [usan:inn]

26. Unii-0p6c6zop5u

27. Roflumilastum

28. Roflumilast (jan/usan/inn)

29. Apta-2217

30. 1xmu

31. 1xoq

32. Daliresp (tn)

33. Roflumilast- Bio-x

34. 3g4l

35. Roflumilast [mi]

36. Roflumilast [inn]

37. Roflumilast [jan]

38. 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-di-chloropyrid-4-yl)benzamide

39. Roflumilast [vandf]

40. Roflumilast [mart.]

41. Schembl19158

42. Roflumilast [who-dd]

43. Mls006010074

44. Roflumilast [ema Epar]

45. Gtpl6962

46. Dtxsid8044123

47. Apta 2217

48. Bdbm14774

49. Roflumilast, >=98% (hplc)

50. Amy4219

51. Ex-a059

52. Roflumilast [orange Book]

53. Hms3655p21

54. Hms3748c19

55. Hms3884f09

56. Zinc592419

57. Act02619

58. Bcp03736

59. S2131

60. Arq-151/zoryve (roflumilast Cream)

61. Akos005146309

62. Am84550

63. Ccg-268678

64. Cs-0963

65. Db01656

66. Pb29130

67. Ncgc00346566-01

68. Ncgc00346566-09

69. Ac-23383

70. As-14120

71. Br164364

72. Hy-15455

73. Smr002530074

74. Sy008710

75. Bcp0726000146

76. Ft-0660846

77. R0193

78. Sw220196-1

79. A24672

80. D05744

81. Ab01565852_02

82. 401r323

83. Q693482

84. J-510858

85. Brd-k03194791-001-02-2

86. 3- Cyclo-propylmethoxy-4-difluoromethoxy-n- [3, 5-di-chloropyrid-4-yl]- Benzamid

87. Benzamide, 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)-

88. N-(3,5-dichloropyridin-4-yl)-4-difluoromethoxy-3-cyclopropylmethoxybenzamide

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 403.2 g/mol
Molecular Formula C17H14Cl2F2N2O3
XLogP34.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count7
Exact Mass402.0349540 g/mol
Monoisotopic Mass402.0349540 g/mol
Topological Polar Surface Area60.4 Ų
Heavy Atom Count26
Formal Charge0
Complexity475
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameDaliresp
PubMed HealthRoflumilast (By mouth)
Drug ClassesRespiratory Agent
Drug LabelThe active ingredient in DALIRESP tablets is roflumilast. Roflumilast and its active metabolite (roflumilast N-oxide) are selective phosphodiesterase 4 (PDE4) inhibitors. The chemical name of roflumilast is N-(3,5-dichloropyridin-4-yl)-3-cyclopropylm...
Active IngredientRoflumilast
Dosage FormTablet
RouteOral
Strength500mcg
Market StatusPrescription
CompanyForest Res Inst

2 of 2  
Drug NameDaliresp
PubMed HealthRoflumilast (By mouth)
Drug ClassesRespiratory Agent
Drug LabelThe active ingredient in DALIRESP tablets is roflumilast. Roflumilast and its active metabolite (roflumilast N-oxide) are selective phosphodiesterase 4 (PDE4) inhibitors. The chemical name of roflumilast is N-(3,5-dichloropyridin-4-yl)-3-cyclopropylm...
Active IngredientRoflumilast
Dosage FormTablet
RouteOral
Strength500mcg
Market StatusPrescription
CompanyForest Res Inst

4.2 Drug Indication

Roflumilast is indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. Roflumilast is not a bronchodilator and is not indicated for the relief of acute bronchospasm.


FDA Label


Daxas is indicated for maintenance treatment of severe chronic obstructive pulmonary disease (COPD) (FEV1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerbations as add-on to bronchodilator treatment.


Libertek is indicated for maintenance treatment of severe chronic obstructive pulmonary disease (COPD) (FEV1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerbations as add-on to bronchodilator treatment.


Daliresp is indicated for maintenance treatment of severe chronic obstructive pulmonary disease (COPD) (FEV1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerbations as add-on to bronchodilator treatment.


Chronic obstructive pulmonary disease


5 Pharmacology and Biochemistry
5.1 Pharmacology

Roflumilast (and its active metabolite, roflumilast N-oxide) increases cyclic adenosine-3, 5-monophosphate (cAMP) in lung cells by inhibiting PDE4. Increased cAMP activates PKA, which inactivates transcription factors involved in inflammation. Romflumilast also decreases the amount of sputum neutrophils and eosinophils in COPD patients.


5.2 FDA Pharmacological Classification
5.2.1 Active Moiety
ROFLUMILAST
5.2.2 FDA UNII
0P6C6ZOP5U
5.2.3 Pharmacological Classes
Phosphodiesterase 4 Inhibitors [MoA]; Phosphodiesterase 4 Inhibitor [EPC]
5.3 ATC Code

R03DX07


R03DX08


R03DX07


R03DX07

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


R - Respiratory system

R03 - Drugs for obstructive airway diseases

R03D - Other systemic drugs for obstructive airway diseases

R03DX - Other systemic drugs for obstructive airway diseases

R03DX07 - Roflumilast


5.4 Absorption, Distribution and Excretion

Absorption

After a 500mcg dose, the bioavailability of roflumilast is about 80%. In the fasted state, maximum plasma concentrations are reached in 0.5 to 2 hours. While in the fed state, Cmax is reduced by 40%, Tmax is increased by one hour, and total absorption is unchanged.


Route of Elimination

Roflumilast is excreted 70% in the urine as roflumilast N-oxide.


Volume of Distribution

Roflumilast has a Vd of 2.9L/kg with a dose of 500mcg. Permeability of roflumilast across the blood-brain barrier appears to be poor in rat studies.


Clearance

~9.6 L/hour.


5.5 Metabolism/Metabolites

Roflumilast is metabolized to roflumilast N-oxide, the active metabolite of roflumilast in humans, by CYP3A4 and CYP1A2.


5.6 Biological Half-Life

Plasma half-life of roflumilast is 17 hours and its metabolite is 30 hours (oral dose).


5.7 Mechanism of Action

Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor which, due to its selective inhibition of the PDE4 isoenzyme, has potential antiinflammatory and antimodulatory effects in the pulmonary system. It is thought that the increased levels of intracellular cyclic AMP are responsible for the therapeutic actions of Roflumilast.


API SUPPLIERS

read-more
read-more

01

Interquim SA

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC arrow-down KDMF arrow-down VMF ASMF arrow-down AUDIT
Interquim

02

M2i Group

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothM2i Group, an integrated CDMO, is your French partner for development & manufacturing in fine chemistry.

Flag France
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
m2i group

03

Inke S.A

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInke S.A: APIs manufacturing plant.

Flag Spain
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Inke Company Banner

04

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

05

HRV Global Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU arrow-down AUDIT
HRV Global Life Sciences

06

Beijing Mesochem Technology

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMesochem is focused on incessant innovation along with the R&D of new APIs.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Mesochem Company Banner

07

Interquim SA

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF ASMF arrow-down AUDIT
Interquim

08

Interquim SA

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF ASMF arrow-down AUDIT
Interquim

09

Hefei TianRui Pharmaceutical Chemi...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AAPS National Biotech
Not Confirmed
arrow

Hefei TianRui Pharmaceutical Chemi...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AAPS National Biotech
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Melody Healthcare

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AAPS National Biotech
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Interquim Sa

Spain
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2015-01-05

Pay. Date : 2014-07-23

DMF Number : 28471

Submission : 2014-07-31

Status : Active

Type : II

Interquim

02

Arvo
Not Confirmed

03

Arvo
Not Confirmed

03

Arvo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2018-06-29

Pay. Date : 2018-06-04

DMF Number : 32851

Submission : 2018-06-01

Status : Active

Type : II

blank

04

Arvo
Not Confirmed

05

Arvo
Not Confirmed

06

Hetero Drugs Ltd

India

USDMF

arrow
Arvo
Not Confirmed

06

Arvo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-11-17

Pay. Date : 2014-08-14

DMF Number : 28516

Submission : 2014-08-27

Status : Active

Type : II

blank

07

Arvo
Not Confirmed

08

Scinopharm Taiwan Ltd

Taiwan

USDMF

arrow
Arvo
Not Confirmed

08

Arvo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-09-08

Pay. Date : 2014-03-13

DMF Number : 26764

Submission : 2012-12-27

Status : Active

Type : II

blank

09

Arvo
Not Confirmed

09

Arvo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-04-21

Pay. Date : 2021-03-04

DMF Number : 35661

Submission : 2021-03-11

Status : Active

Type : II

blank

10

Arvo
Not Confirmed

10

Arvo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-11-11

Pay. Date : 2014-08-04

DMF Number : 28440

Submission : 2014-09-04

Status : Active

Type : II

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Interquim SA

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content

Roflumilast

About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs...

Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs that meet stringent quality standards. Complying with European environmental and work safety regulations, Interquim’s products are exported to highly regulated pharmaceutical markets. Regulatory bodies and clients have approved its quality system and facilities. With state-of-the-art multi-production plants, drug synthesis, and quality-control labs, Interquim supports clients throughout the entire product lifecycle, from product development to marketing.
Interquim

02

M2i Group

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothM2i Group, an integrated CDMO, is your French partner for development & manufacturing in fine chemistry.

Flag France
Digital Content Digital Content

Roflumilast

About the Company : Integrated solutions for all your projects.
M2i Group provides integrated solutions for all your projects. We offer our clients an integrated partner, from early development...

Integrated solutions for all your projects. M2i Group provides integrated solutions for all your projects. We offer our clients an integrated partner, from early development to commercial supply of high-value niche fine chemicals for the pharmaceutical and biocontrol industry. Our offerings include: - Proprietary molecule portfolio: API, synthesis intermediates, key building blocks & pheromones - Custom development & manufacturing: Process development, industrialization & production - Contract Research: Outsourced research services - Consulting/accompaniment: R&D, innovation, key sourcing & industrial strategy
m2i group

03

Inke S.A

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInke S.A: APIs manufacturing plant.

Flag Spain
Digital Content Digital Content

Roflumilast

About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...

Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation.
Inke Company Banner

04

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Roflumilast

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Roflumilast

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMesochem is focused on incessant innovation along with the R&D of new APIs.

Flag China
Digital Content Digital Content

Roflumilast

About the Company : Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine c...

Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine chemicals and fundamental chemical materials. It has an efficient research and development team. Beijing Mesochem provides its customers customized development, craft optimization, contract customization and outsourcing services. The company has a well-established industrial base in Weinan, Shanxi Province. The production base features a 20,000 ㎡ plant with a production capacity of over 8,000 MT per year.
Mesochem Company Banner

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Roflumilast

About the Company : Chongqing Huapont Pharmaceutical Co., Ltd. was established in 1994 and is now located in Liangjiang New District, Chongqing. It is a national high-tech enterprise, a national innov...

Chongqing Huapont Pharmaceutical Co., Ltd. was established in 1994 and is now located in Liangjiang New District, Chongqing. It is a national high-tech enterprise, a national innovative enterprise, and a national demonstration enterprise for a new model of intelligent manufacturing. It has a national enterprise technology center and multiple municipal R&D platforms, two formulation factories, and two API factories. In addition, the company is also widely involved in the fields of respiratory, cardiovascular and cerebrovascular, blood, tumor, and systemic hormones, and has accumulated a large number of blockbuster drugs.
blank

08

DEAFARMA

Italy
Arvo
Not Confirmed
arrow

DEAFARMA

Italy
arrow
Arvo
Not Confirmed

Roflumilast

About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...

In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territory. DEAFARMA works with success in the pharmaceutical raw materials field through Agencies and professional relations with the most important European and Asiatic factories. Our partners are well known, reliable producers and all of them are operating in accordance with the latest GMP Rules. The APIs mentioned in the DEAFARMA catalogue are always supported by DMF and/or CEP.
blank

09

Hetero Drugs

India
Arvo
Not Confirmed
arrow

Hetero Drugs

India
arrow
Arvo
Not Confirmed

Roflumilast

About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs. Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.
blank

10

Lee Pharma

India
Arvo
Not Confirmed
arrow

Lee Pharma

India
arrow
Arvo
Not Confirmed

Roflumilast

About the Company : Founded in 1997, Lee Pharma Limited has transformed from a small venture into a global leader in the pharmaceutical industry. Our journey began with a commitment to providing affor...

Founded in 1997, Lee Pharma Limited has transformed from a small venture into a global leader in the pharmaceutical industry. Our journey began with a commitment to providing affordable and high-quality healthcare solutions. Through advanced research, modern manufacturing, and a strong emphasis on quality, we are dedicated to producing medicines that enhance lives. Lee Pharma is a research-focused company that prioritizes the development, synthesis, and commercialization of high-quality Active Pharmaceutical Ingredients (APIs), intermediate chemicals, and finished formulations.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"ROFLUMILAST","year":"2021","qtr":"Q1","strtotime":1610044200,"product":"ROFLUMILAST IH","address":"HETERO HOUSE, H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD-A.P.","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"TEL AVIV YAFO","customer":"PERRIGO COMPANY PLC","customerCountry":"ISRAEL","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"180321.4","totalValueFC":"1825.7","currency":"USD","unitRateINR":13352800,"date":"08-Jan-2021","totalValueINR":"133528","totalValueInUsd":"1825.7","indian_port":"HYDERABAD AIR","hs_no":"29333911","bill_no":"7764282","productDescription":"API","marketType":"","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO HOUSE, H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD-A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1622485800,"product":"ROFLUMILAST (TAX INVOICE NO:1900215171 DT:24-05-2021) (GROUP:A","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"TEL AVIV YAFO","customer":"PERRIGO COMPANY PLC","customerCountry":"ISRAEL","quantity":"0.01","actualQuantity":"0.007","unit":"KGS","unitRateFc":"251040.9","totalValueFC":"1721.6","currency":"USD","unitRateINR":18087500,"date":"01-Jun-2021","totalValueINR":"126612.5","totalValueInUsd":"1721.6","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"2146621","productDescription":"API","marketType":"","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637519400,"product":"ROFLUMILAST (TAX INVOICE NO:1900215903","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"SUN PHARMACEUTICAL INDUSTRIES LIMITED","customerCountry":"CANADA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"200000","totalValueFC":"58908.6","currency":"USD","unitRateINR":14623333.333333334,"date":"22-Nov-2021","totalValueINR":"4387000","totalValueInUsd":"58908.6","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"6169958","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640111400,"product":"ROFLUMILAST IH","address":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"WESTERN PHARMACEUTICAL INDUSTRIES","customerCountry":"EGYPT","quantity":"0.43","actualQuantity":"0.425","unit":"KGS","unitRateFc":"120000","totalValueFC":"50884.2","currency":"USD","unitRateINR":9030588.2352941185,"date":"22-Dec-2021","totalValueINR":"3838000","totalValueInUsd":"50884.2","indian_port":"HYDERABAD AIR","hs_no":"29333911","bill_no":"6930810","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648233000,"product":"339977 - ROFLUMILAST - NN4297","address":"SITE NO.1,BOMMASANDRA INDL.AREA,IV ,PHASE,JIGANI LINK ROAD ANEKAL TALU","city":"BANGALORE,KARNATAKA","supplier":"APOTEX INC","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"ADLI LOGISTICS","customerCountry":"CANADA","quantity":"0.16","actualQuantity":"0.159","unit":"KGS","unitRateFc":"79078.1","totalValueFC":"12411.5","currency":"USD","unitRateINR":5949685.5345911952,"date":"26-Mar-2022","totalValueINR":"946000","totalValueInUsd":"12411.5","indian_port":"BANGALORE ICD","hs_no":"29331999","bill_no":"9222536","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE ICD","supplierAddress":"SITE NO.1,BOMMASANDRA INDL.AREA,IV ,PHASE,JIGANI LINK ROAD ANEKAL TALU, BANGALORE,KARNATAKA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1656873000,"product":"ROFLUMILAST","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"TO THE ORDER OF","customerCountry":"CHINA","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"225000","totalValueFC":"327101.8","currency":"USD","unitRateINR":17340000,"date":"04-Jul-2022","totalValueINR":"26010000","totalValueInUsd":"327101.8","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"2594140","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1674239400,"product":"ROFLUMILAST, REF NO. S_22_0429382, PRPN.","address":"TORRENT HOUSE, OFF ASHRAM ROAD,","city":"AHMEDABAD","supplier":"TORRENT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"JASPER HOLZER,DEPUTY HEAD OF QC-","customerCountry":"GERMANY","quantity":"0.00","actualQuantity":"4","unit":"GMS","unitRateFc":"122.1","totalValueFC":"513.7","currency":"EUR","unitRateINR":10500,"date":"21-Jan-2023","totalValueINR":"42000","totalValueInUsd":"513.7","indian_port":"DELHI AIR","hs_no":"29339990","bill_no":"7144954","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"TORRENT HOUSE, OFF ASHRAM ROAD,, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1674239400,"product":"ROFLUMILAST, REF NO. S_22_0429382, PRPN.","address":"TORRENT HOUSE, OFF ASHRAM ROAD,","city":"AHMEDABAD","supplier":"TORRENT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"JASPER HOLZER,DEPUTY HEAD OF QC-","customerCountry":"GERMANY","quantity":"0.00","actualQuantity":"4","unit":"GMS","unitRateFc":"122.1","totalValueFC":"513.7","currency":"EUR","unitRateINR":10500,"date":"21-Jan-2023","totalValueINR":"42000","totalValueInUsd":"513.7","indian_port":"DELHI AIR","hs_no":"29339990","bill_no":"7145054","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"TORRENT HOUSE, OFF ASHRAM ROAD,, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677177000,"product":"ROFLUMILAST STANDARD FOR TESTING PURPOSE","address":"TORRENT HOUSE, OFF ASHRAM ROAD,","city":"AHMEDABAD","supplier":"TORRENT PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"ACE LABORATORIES","customerCountry":"UNITED KINGDOM","quantity":"0.00","actualQuantity":"1.5","unit":"GMS","unitRateFc":"105.6","totalValueFC":"193.7","currency":"GBP","unitRateINR":10666.666666666666,"date":"24-Feb-2023","totalValueINR":"16000","totalValueInUsd":"193.7","indian_port":"DELHI AIR","hs_no":"29339990","bill_no":"8040697","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"TORRENT HOUSE, OFF ASHRAM ROAD,, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1691087400,"product":"CS-O-11739 \/ ROFLUMILAST","address":"NA","city":"MUMBAI","supplier":"CLEARSYNTH LABS LIMITED","supplierCountry":"INDIA","foreign_port":"HO CHI MINH CITY","customer":"NAVIS VIETNAM CO LIMITED","customerCountry":"VIETNAM","quantity":"0.00","actualQuantity":"1","unit":"GMS","unitRateFc":"240","totalValueFC":"236.6","currency":"USD","unitRateINR":19600.308000000001,"date":"04-Aug-2023","totalValueINR":"19600.308","totalValueInUsd":"236.6","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"","country":"VIETNAM","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"NA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692210600,"product":"CS-O-11739 \/ ROFLUMILAST","address":"17 LOTUS BUSINESS PARKNEW LINK RD ANDHERI W","city":"MUMBAI","supplier":"CLEARSYNTH LABS LIMITED","supplierCountry":"INDIA","foreign_port":"HO CHI MINH CITY","customer":"ONLAB SCIENTIFIC CO LIMITED","customerCountry":"VIETNAM","quantity":"0.00","actualQuantity":"1","unit":"GMS","unitRateFc":"240","totalValueFC":"236.6","currency":"USD","unitRateINR":19600.308000000001,"date":"17-Aug-2023","totalValueINR":"19600.308","totalValueInUsd":"236.6","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"0","productDescription":"API","marketType":"","country":"VIETNAM","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"17 LOTUS BUSINESS PARKNEW LINK RD ANDHERI W, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696617000,"product":"ROFLUMILAST","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TO THE ORDER OF,....;;","customerCountry":"CANADA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"100000","totalValueFC":"98679.2","currency":"USD","unitRateINR":8213000,"date":"07-Oct-2023","totalValueINR":"8213000","totalValueInUsd":"98679.2","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"4469065","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1699209000,"product":"ROFLUMILAST","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO THE ORDER OF.;;.;","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"180000","totalValueFC":"53259.9","currency":"USD","unitRateINR":14783333.333333334,"date":"06-Nov-2023","totalValueINR":"4435000","totalValueInUsd":"53259.9","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5158208","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1699813800,"product":"ROFLUMILAST USP","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"TO THE ORDER OF","customerCountry":"CHINA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"225000","totalValueFC":"222130.5","currency":"USD","unitRateINR":18497000,"date":"13-Nov-2023","totalValueINR":"18497000","totalValueInUsd":"222130.5","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"5328203","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720636200,"product":"ROFLUMILAST","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"PHARMAPIA CO. LTD","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"180000","totalValueFC":"53343.7","currency":"USD","unitRateINR":14863526.666666668,"date":"11-Jul-2024","totalValueINR":"4459058","totalValueInUsd":"53343.7","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"2344233","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741113000,"product":"ROFLUMILAST","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"PHARMAPIA CO. LTD","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"165000","totalValueFC":"49091.7","currency":"USD","unitRateINR":14174013.333333334,"date":"05-Mar-2025","totalValueINR":"4252204","totalValueInUsd":"49091.7","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"8747276","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663180200,"product":"ROFLUMILAST (QTY: 1 X 500 MG, VALUE: USD 830)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"USP","supplierCountry":"CHINA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0005","unit":"KGS","unitRateFc":"1660000","totalValueFC":"852","currency":"USD","unitRateINR":"136554720","date":"15-Sep-2022","totalValueINR":"68277.36","totalValueInUsd":"852","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"2455874","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727289000,"product":"ROFLUMILAST (QTY:1 X 500 MG, VALUE: USD 855) (FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"UNITED STATES PHARMACOPEIAL","supplierCountry":"CHINA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0005","unit":"KGS","unitRateFc":"1710000","totalValueFC":"876.1","currency":"USD","unitRateINR":"146835100","date":"26-Sep-2024","totalValueINR":"73417.55","totalValueInUsd":"876.1","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"5817747","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,M D,US 21704, UNITED STATES OF AMERIC A United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"}]
08-Jan-2021
05-Mar-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 250MCG

USFDA APPLICATION NUMBER - 22522

read-more

DOSAGE - TABLET;ORAL - 500MCG

USFDA APPLICATION NUMBER - 22522

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

Solubilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Controlled & Modified Release

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Taste Masking

read-more
read-more

Parenteral

read-more
read-more

Coating Systems & Additives

read-more
read-more

Emulsifying Agents

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 162401-32-3 / Roflumilast API manufacturers, exporters & distributors?

Roflumilast manufacturers, exporters & distributors 1

48

PharmaCompass offers a list of Roflumilast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Roflumilast manufacturer or Roflumilast supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Roflumilast manufacturer or Roflumilast supplier.

PharmaCompass also assists you with knowing the Roflumilast API Price utilized in the formulation of products. Roflumilast API Price is not always fixed or binding as the Roflumilast Price is obtained through a variety of data sources. The Roflumilast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Roflumilast

Synonyms

162401-32-3, Daxas, 3-(cyclopropylmethoxy)-n-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide, Daliresp, By217, Byk20869

Cas Number

162401-32-3

Unique Ingredient Identifier (UNII)

0P6C6ZOP5U

About Roflumilast

Roflumilast is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3',5'-adenosine monophosphate (cAMP) and cAMP-mediated signaling. cAMP prevents phosphorylation of spleen tyrosine kinase (SYK) and abrogates activation of the PI3K/AKT/mTOR signaling pathway, which may result in the induction of apoptosis. PDE4, a member of the PDE superfamily that hydrolyses cAMP and 3',5'-cyclic guanosine monophosphate (cGMP) to their inactive 5' monophosphates, is upregulated in a variety of cancers and may contribute to chemoresistance; it also plays a key role in inflammation, especially in inflammatory airway diseases.

ROF Manufacturers

A ROF manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ROF, including repackagers and relabelers. The FDA regulates ROF manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ROF API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of ROF manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

ROF Suppliers

A ROF supplier is an individual or a company that provides ROF active pharmaceutical ingredient (API) or ROF finished formulations upon request. The ROF suppliers may include ROF API manufacturers, exporters, distributors and traders.

click here to find a list of ROF suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

ROF USDMF

A ROF DMF (Drug Master File) is a document detailing the whole manufacturing process of ROF active pharmaceutical ingredient (API) in detail. Different forms of ROF DMFs exist exist since differing nations have different regulations, such as ROF USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A ROF DMF submitted to regulatory agencies in the US is known as a USDMF. ROF USDMF includes data on ROF's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The ROF USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of ROF suppliers with USDMF on PharmaCompass.

ROF KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a ROF Drug Master File in Korea (ROF KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of ROF. The MFDS reviews the ROF KDMF as part of the drug registration process and uses the information provided in the ROF KDMF to evaluate the safety and efficacy of the drug.

After submitting a ROF KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their ROF API can apply through the Korea Drug Master File (KDMF).

click here to find a list of ROF suppliers with KDMF on PharmaCompass.

ROF WC

A ROF written confirmation (ROF WC) is an official document issued by a regulatory agency to a ROF manufacturer, verifying that the manufacturing facility of a ROF active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting ROF APIs or ROF finished pharmaceutical products to another nation, regulatory agencies frequently require a ROF WC (written confirmation) as part of the regulatory process.

click here to find a list of ROF suppliers with Written Confirmation (WC) on PharmaCompass.

ROF NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ROF as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for ROF API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture ROF as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain ROF and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ROF NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of ROF suppliers with NDC on PharmaCompass.

ROF GMP

ROF Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of ROF GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ROF GMP manufacturer or ROF GMP API supplier for your needs.

ROF CoA

A ROF CoA (Certificate of Analysis) is a formal document that attests to ROF's compliance with ROF specifications and serves as a tool for batch-level quality control.

ROF CoA mostly includes findings from lab analyses of a specific batch. For each ROF CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

ROF may be tested according to a variety of international standards, such as European Pharmacopoeia (ROF EP), ROF JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ROF USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty